Are antioxidants useful for treating skeletal muscle atrophy?

Free Radical Biology and Medicine

Volumn 47, Issue 7, 2009, Pages 906-916

  Bonetto, Andrea ^a   Penna, Fabio ^a   Muscaritoli, Maurizio ^b   Minero, Valerio G ^a   Fanelli, Filippo Rossi ^b   Baccino, Francesco M ^a   Costelli, Paola ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antioxidants; Atrophy; Free radicals; Oxidative stress; Protein breakdown; Reactive oxygen species; Skeletal muscle

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CARNITINE; CYSTEINE; EPIGALLOCATECHIN GALLATE; GLUTAMINE; GLUTATHIONE; MELATONIN; MUSCLE PROTEIN; ORNITHINE; PRASTERONE; PYRIDOXAMINE; REACTIVE OXYGEN METABOLITE; RESVERATROL; THIOCTIC ACID; UBIDECARENONE;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; CACHEXIA; DIABETES MELLITUS; DRUG EFFICACY; DRUG MEGADOSE; DRUG TARGETING; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; MUSCLE ATROPHY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SOLID TUMOR;

ANIMALS; ANTIOXIDANTS; HUMANS; MUSCLE PROTEINS; MUSCULAR DISORDERS, ATROPHIC; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 69249213367     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.07.002     Document Type: Review

References (155)

1. Costelli P., and Baccino F.M. Mechanisms of skeletal muscle depletion in wasting syndromes: role of ATP-ubiquitin-dependent proteolysis. Curr. Opin. Clin. Nutr. Metab. Care 6 (2003) 407-412
2. Kadowaki M., and Kanazawa T. Amino acids as regulators of proteolysis. J. Nutr. 133 (2003) 2052S-2056S
3. Mizushima N., Yamamoto A., Matsui M., Yoshimori T., and Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. Biol. Cell 15 (2004) 1101-1111
4. Marino G., Uria J.A., Puente X.S., Quesada V., Bordallo J., and Lopez-Otin C. Human autophagins, a family of cysteine proteinases potentially implicated in cell degradation by autophagy. J. Biol. Chem. 278 (2003) 3671-3678
5. Mammucari C., Milan G., Romanello V., Masiero E., Rudolf R., Del Piccolo P., Burden S.J., Di Lisi R., Sandri C., Zhao J., Goldberg A.L., Schiaffino S., and Sandri M. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 6 (2007) 458-471
6. Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., Poueymirou W.T., Panaro F.J., Na E., Dharmarajan K., Pan Z.Q., Valenzuela D.M., DeChiara T.M., Stitt T.N., Yancopoulos G.D., and Glass D.J. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294 (2001) 1704-1708
7. 2+-dependent proteolysis in muscle wasting. Int. J. Biochem. Cell Biol. 37 (2005) 2134-2146
8. Smith I.J., and Dodd S.L. Calpain activation causes a proteasome-dependent increase in protein degradation and inhibits the Akt signalling pathway in rat diaphragm muscle. Exp. Physiol. 92 (2007) 561-573
9. Du J., Wang X., Miereles C., Bailey J.L., Debigare R., and Zheng B. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J. Clin. Invest. 113 (2004) 115-123
10. Wei W., Fareed M.U., Evenson A., Menconi M.J., Yang H., Petkova V., and Hasselgren P.O. Sepsis stimulates calpain activity in skeletal muscle by decreasing calpastatin activity but does not activate caspase-3. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 (2005) R580-R590
11. Moresi V., Presterà A., Scicchitano B.M., Molinaro M., Teodori L., Sassoon D., Adamo S., and Coletti D. Tumor necrosis factor-alpha inhibition of skeletal muscle regeneration is mediated by a caspase-dependent stem cell response. Stem Cells 26 (2008) 997-1008
12. Ruff R.L., and Secrist D. Inhibitors of prostaglandin synthesis or cathepsin B prevent muscle wasting due to sepsis in the rat. J. Clin. Invest. 73 (1984) 1483-1486
13. Tessitore L., Costelli P., and Baccino F.M. Pharmacological interference with tissue protein hypercatabolism in tumor-bearing rats. Biochem. J. 299 (1994) 71-78
14. Heslin M.J., Newman E., Wolf R.F., Pisters P.W., and Brennan M.F. Effect of systemic hyperinsulinemia in cancer patients. Cancer Res. 52 (1992) 3845-3850
15. Hasselgren P.O. Glucocorticoids and muscle catabolism. Curr. Opin. Clin. Nutr. Metab. Care 2 (1999) 201-205
16. Wing S.S., and Goldberg A.L. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am. J. Physiol. 264 (1993) E668-E676
17. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., Walsh K., Schiaffino S., Lecker S.H., and Goldberg A.L. FoxO transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117 (2004) 399-412
18. Stitt T.N., Drujan D., Clarke B.A., Panaro F., Timofeyva Y., Kline W.O., Gonzalez M., Yancopoulos G.D., and Glass D.J. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 14 (2004) 395-403
19. Argilés J.M., Busquets S., Felipe A., and López-Soriano F.J. Muscle wasting in cancer and ageing: cachexia versus sarcopenia. Adv. Gerontol. 18 (2006) 39-54
20. Matthys P., Heremans H., Opdenakker G., and Billiau A. Anti-interferon-gamma antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia. Eur. J. Cancer 27 (1991) 182-187
21. Strassmann G., Fong M., Kenney J.S., and Jacob C.O. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Invest. 89 (1992) 1681-1684
22. Tsujinaka T., Fujita J., Ebisui C., Yano M., Kominami E., Suzuki K., Tanaka K., Katsume A., Ohsugi Y., Shiozaki H., and Monden M. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J. Clin. Invest. 97 (1996) 244-249
23. Roubenoff R., Parise H., Payette H.A., Abad L.W., D'Agostino R., Jacques P.F., Wilson P.W., Dinarello C.A., and Harris T.B. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am. J. Med. 115 (2003) 429-435
24. Todorov P., Cariuk P., McDevitt T., Coles B., Fearon K., and Tisdale M. Characterization of a cancer cachectic factor. Nature 379 (1996) 739-742
25. Tisdale M.J. Molecular pathways leading to cancer cachexia. Physiology 20 (2005) 340-348
26. Jatoi A., Foster N., Wieland B., Murphy B., Nikcevich D., LaPlant B., Palcic M.M., and Baracos V. The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer. Dis. Esophagus 19 (2006) 241-247
27. Wieland B.M., Stewart G.D., Skipworth R.J., Sangster K., Fearon K.C., Ross J.A., Reiman T.J., Easaw J., Mourtzakis M., Kumar V., Pak B.J., Calder K., Filippatos G., Kremastinos D.T., Palcic M., and Baracos V.E. Is there a human homologue to the murine proteolysis-inducing factor?. Clin. Cancer Res. 13 (2007) 4984-4992
28. Martin K.R., and Barrett J.C. Reactive oxygen species as double-edged swords in cellular processes: low-dose cell signaling versus high-dose toxicity. Hum. Exp. Toxicol. 21 (2002) 71-75
29. Zhang Y., Eriksson M., Dallner G., and Appelkvist E.L. Analysis of ubiquinone and tocopherol levels in normal and hyperlipidemic human plasma. Lipids 33 (1998) 811-815
30. Halliwell B., and Gutteridge J.M. The definition and measurement of antioxidants in biological systems. Free Radic. Biol. Med. 18 (1995) 125-126
31. Manoli I., Le H., Alesci S., McFann K.K., Su Y.A., Kino T., Chrousos G.P., and Blackman M.R. Monoamine oxidase-A is a major target gene for glucocorticoids in human skeletal muscle cells. FASEB J. 19 (2005) 1359-1361
32. Judge A.R., and Dodd S.L. Xanthine oxidase and activated neutrophils cause oxidative damage to skeletal muscle after contractile claudication. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H252-H256
33. Wallwork C.J., Parks D.A., and Schmid-Schönbein G.W. Xanthine oxidase activity in the dexamethasone-induced hypertensive rat. Microvasc. Res. 66 (2003) 30-37
34. Xia R., Webb J.A., Gnall L.L., Cutler K., and Abramson J.J. Skeletal muscle sarcoplasmic reticulum contains a NADH-dependent oxidase that generates superoxide. Am. J. Physiol. Cell. Physiol. 285 (2003) C215-C221
35. Stamler J.S., and Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol. Rev. 81 (2001) 209-237
36. Silvagno F., Xia H., and Bredt D.S. Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J. Biol. Chem. 271 (1996) 11204-11208
37. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15 (1997) 323-350
38. 2{radical dot}: a pulse radiolysis study. Free Radic. Biol. Med. 19 (1995) 505-510
39. Klebanoff S.J. Myeloperoxidase: friend and foe. J. Leukocyte Biol. 77 (2005) 598-625
40. Fridovich I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64 (1995) 97-112
41. Jenkins R.R. Exercise, oxidative stress, and antioxidants: a review. Int. J. Sport Nutr. 3 (1993) 356-375
42. Ji L.L., Fu R., and Mitchell E.W. Glutathione and antioxidant enzymes in skeletal muscle: effects of fiber type and exercise intensity. J. Appl. Physiol. 73 (1992) 1854-1859
43. Crapo J.D., Oury T., Rabouille C., Slot J.W., and Chang L.Y. Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc. Natl. Acad. Sci. USA 89 (1992) 10405-10409
44. Fukai T., Folz R.J., Landmesser U., and Harrison D.G. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc. Res. 55 (2002) 239-249
45. Kinnula V.L., and Crapo J.D. Superoxide dismutases in malignant cells and human tumors. Free Radic. Biol. Med. 36 (2004) 718-744
46. Cheeseman K.H., and Slater T.F. An introduction to free radical biochemistry. Br. Med. Bull. 49 (1993) 481-493
47. Hansen J.M., Zhang H., and Jones D.P. Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions. Free Radic. Biol. Med. 40 (2006) 138-145
48. Watson W.H., Yang X., Choi Y.E., Jones D.P., and Kehrer J.P. Thioredoxin and its role in toxicology. Toxicol. Sci. 78 (2004) 3-14
49. McEligot A.J., Yang S., and Meyskens Jr. F.L. Redox regulation by intrinsic species and extrinsic nutrients in normal and cancer cells. Annu. Rev. Nutr. 25 (2005) 261-295
50. Wink D.A., Hanbauer I., Krishna M.C., DeGraff W., Gamson J., and Mitchell J.B. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. USA 90 (1993) 9813-9817
51. Moylan J.S., and Reid M.B. Oxidative stress, chronic disease, and muscle wasting. Muscle Nerve 35 (2007) 411-429
52. Vasilaki A., McArdle F., Iwanejko L.M., and McArdle A. Adaptive responses of mouse skeletal muscle to contractile activity: the effect of age. Mech. Ageing Dev. 127 (2006) 830-839
53. Ji L.L. Modulation of skeletal muscle antioxidant defense by exercise: role of redox signaling. Free Radic. Biol. Med. 44 (2008) 142-152
54. Jackson M.J., Papa S., Bolanos J., Bruckdorfer R., Carlsen H., Elliott R.M., Flier J., Griffiths H.R., Heales S., Holst B., Lorusso M., Lund E., Øivind Moskaug J., Moser U., DiPaola M., Polidori M.C., Signorile A., Stahl W., Vina-Ribes J., and Astley S.B. Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function. Mol. Aspects Med. 23 (2002) 209-285
55. Reid M.B. Nitric oxide, reactive oxygen species, and skeletal muscle contraction. Med. Sci. Sports Exerc. 33 (2001) 371-376
56. Reid M.B., Khawli F.A., and Moody M.R. Reactive oxygen in skeletal muscle. III. Contractility of unfatigued muscle. J. Appl. Physiol. 75 (1993) 1081-1087
57. Zima A.V., and Blatter L.A. Redox regulation of cardiac calcium channels and transporters. Cardiovasc. Res. 71 (2006) 310-321
58. Smith M., and Reid M.B. Redox modulation of contractile function in respiratory and limb skeletal muscle. Respir. Physiol. Neurobiol. 151 (2006) 229-241
59. Patel J., McLeod L.E., Vries R.G., Flynn A., Wang X., and Proud C.G. Cellular stresses profoundly inhibit protein synthesis and modulate the states of phosphorylation of multiple translation factors. Eur. J. Biochem. 269 (2002) 3076-3085
60. Goldspink D.F., Morton A.J., Loughna P., and Goldspink G. The effect of hypokinesia and hypodynamia on protein turnover and the growth of four skeletal muscles of the rat. Pflugers Arch. 407 (1986) 333-340
61. Thomason D.B., Biggs R.B., and Booth F.W. Protein metabolism and beta-myosin heavy-chain mRNA in unweighted soleus muscle. Am. J. Physiol. 257 (1989) R300-R305
62. Lang C.H., Frost R.A., Nairn A.C., and MacLean D.A. Vary, T.C. TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E336-E347
63. MacFarlane N.G., and Miller D.J. Depression of peak force without altering calcium sensitivity by the superoxide anion in chemically skinned cardiac muscle of rat. Circ. Res. 70 (1992) 1217-1224
64. Buck M., and Chojkier M. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J. 15 (1996) 1753-1765
65. Li Y.P., Schwartz R.J., Waddell I.D., and Holloway B.R. Reid, M.B. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor. FASEB J.12 (1998) 871-880
66. Li Y.P., Chen Y., Li A.S., and Reid M.B. Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am. J. Physiol. Cell. Physiol. 285 (2003) 806-812
67. Gomes-Marcondes M.C., and Tisdale M.J. Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress. Cancer Lett. 180 (2002) 69-74
68. Busquets S., Garcia-Martínez C., Olivan M., Barreiro E., López-Soriano F.J., and Argilés J.M. Overexpression of UCP3 in both murine and human myotubes is linked with the activation of proteolytic systems: a role in muscle wasting?. Biochim. Biophys. Acta 1760 (2006) 253-258
69. Li Y.P., Lecker S.H., Chen Y., Waddell I.D., Goldberg A.L., and Reid M.B. TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J. 17 (2003) 1048-1057
70. Williams G., Brown T., Becker L., Prager M., and Giroir B.P. Cytokine-induced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes. Am. J. Physiol. 267 (1994) R1020-R1025
71. Glass D.J. Skeletal muscle hypertrophy and atrophy signaling pathways. Int. J. Biochem. Cell Biol. 37 (2005) 1974-1984
72. Li Y.P., Chen Y., John J., Moylan J., Jin B., Mann D.L., and Reid M.B. TNF-α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J. 19 (2005) 362-370
73. Matsukawa J., Matsuzawa A., Takeda K., and Ichijo H. The ASK1-MAP kinase cascades in mammalian stress response. J. Biochem. 136 (2004) 261-265
74. Essers M.A., Weijzen S., de Vries-Smits A.M., Saarloos I., de Ruiter N.D., Bos J.L., and Burgering B.M. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 23 (2004) 4802-4812
75. Dillard C.J., Litov R.E., Savin W.M., Dumelin E.E., and Tappel A.L. Effects of exercise, vitamin E, and ozone on pulmonary function and lipid peroxidation. J. Appl. Physiol. 45 (1978) 927-932
76. Terman A., and Brunk U.T. Myocyte aging and mitochondrial turnover. Exp. Gerontol. 39 (2004) 701-705
77. Figueiredo P.A., Mota M.P., Appell H.J., and Duarte J. Ceasing of muscle function with aging: is it the consequence of intrinsic muscle degeneration or a secondary effect of neuronal impairments?. Eur. Rev. Aging Phys. Act. 3 (2006) 75-83
78. Shigenaga M.K., Hagen T.M., and Ames B.N. Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. USA 91 (1994) 10771-10778
79. Cadenas E., and Davies K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29 (2000) 222-230
80. Stadtman E.R. Importance of individuality in oxidative stress and aging. Free Radic. Biol. Med. 33 (2002) 597-604
81. Musarò A., McCullagh K., Paul A., Houghton L., Dobrowolny G., Molinaro M., Barton E.R., Sweeney H.L., and Rosenthal N. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 27 (2001) 195-200
82. Naderi J., Hung M., and Pandey S. Oxidative stress-induced apoptosis in dividing fibroblasts involves activation of p38 MAP kinase and over-expression of Bax: resistance of quiescent cells to oxidative stress. Apoptosis 8 (2003) 91-100
83. Chong Z.Z., Li F., and Maiese K. Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res. Rev. 49 (2005) 1-21
84. Prasad V., Chandele A., Jagtap J.C., Sudheer Kumar P., and Shastry P. ROS-triggered caspase 2 activation and feedback amplification loop in β-carotene-induced apoptosis. Free Radic. Biol. Med. 41 (2006) 431-442
85. Chaput J.P., Lord C., Cloutier M., Aubertin Leheudre M., Goulet E.D., Rousseau S., Khalil A., and Dionne I.J. Relationship between antioxidant intakes and class I sarcopenia in elderly men and women. J. Nutr. Health Aging 11 (2007) 363-369
86. Semba R.D., Blaum C., Guralnik J.M., Moncrief D.T., Ricks M.O., and Fried L.P. Carotenoid and vitamin E status are associated with indicators of sarcopenia among older women living in the community. Aging Clin. Exp. Res. 15 (2003) 482-487
87. Cesari M., Pahor M., Bartali B., Cherubini A., Penninx B.W., Williams G.R., Atkinson H., Martin A., Guralnik J.M., and Ferrucci L. Antioxidants and physical performance in elderly persons: the Invecchiare in Chianti (InCHIANTI) study. Am. J. Clin. Nutr. 79 (2004) 289-294
88. Gomez-Cabrera M.C., Domenech E., and Viña J. Moderate exercise is an antioxidant: upregulation of antioxidant genes by training. Free Radic. Biol. Med. 44 (2008) 126-131
89. Karasek M. Does melatonin play a role in aging processes?. J. Physiol. Pharmacol. 58 (2007) 105-113
90. Boots A.W., Haenen G.R., and Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 585 (2008) 325-337
91. Harikumar K.B., and Aggarwal B.B. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7 (2008) 1020-1035
92. Semba R.D., Varadhan R., Bartali B., Ferrucci L., Ricks M.O., Blaum C., and Fried L.P. Low serum carotenoids and development of severe walking disability among older women living in the community: the women's health and aging study I. Age Ageing 36 (2007) 62-67
93. Roman B., Carta L., Martínez-González M.A., and Serra-Majem L. Effectiveness of the Mediterranean diet in the elderly. Clin. Interv. Aging 3 (2008) 97-109
94. Andriollo-Sanchez M., Hininger-Favier I., Meunier N., Venneria E., O'Connor J.M., Maiani G., Polito A., Bord S., Ferry M., Coudray C., and Roussel A.M. No antioxidant beneficial effect of zinc supplementation on oxidative stress markers and antioxidant defenses in middle-aged and elderly subjects: the Zenith study. J. Am. Coll. Nutr. 27 (2008) 463-469
95. Sharman I.M., Down M.G., and Sen R.N. The effects of vitamin E and training on physiological function and athletic performance in adolescent swimmers. Br. J. Nutr. 26 (1971) 265-276
96. Malm C., Svensson M., Sjöberg B., Ekblom B., and Sjödin B. Supplementation with ubiquinone-10 causes cellular damage during intense exercise. Acta Physiol. Scand. 157 (1996) 511-512
97. Gomez-Cabrera M.C., Domenech E., Romagnoli M., Arduini A., Borras C., Pallardo F.V., Sastre J., and Viña J. Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance. Am. J. Clin. Nutr. 87 (2008) 142-149
98. Aragno M., Parola S., Brignardello E., Mauro A., Tamagno E., Manti R., Danni O., and Boccuzzi G. Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes 49 (2000) 1924-1931
99. Ziegler D. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Treat. Endocrinol. 3 (2004) 173-189
100. Leoncini S., Rossi V., Signorini C., Tanganelli I., Comporti M., and Ciccoli L. Oxidative stress, erythrocyte ageing and plasma non-protein-bound iron in diabetic patients. Free Radic Res. 42 (2008) 716-724
101. Zhou L.Z.H., Johnson A.P., and Rando T.A. NFκB and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic. Biol. Med. 31 (2001) 1405-1416
102. Aragno M., Mastrocola R., Catalano M.G., Brignardello E., Danni O., and Boccuzzi G. Oxidative stress impairs skeletal muscle repair in diabetic rats. Diabetes 53 (2004) 1082-1088
103. Costelli P., Almendro V., Figueras M.T., Reffo P., Penna F., Aragno M., Mastrocola R., Boccuzzi G., Busquets S., Bonelli G., Lopez Soriano F.J., Argiles J.M., and Baccino F.M. Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy. Biochim. Biophys. Acta 1770 (2007) 1028-1036
104. Lowell B.B., and Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science 307 (2005) 384-387
105. Simoneau J.A., and Kelley D.E. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J. Appl. Physiol. 83 (1997) 166-171
106. Petersen K.F., Dufour S., Befroy D., Garcia R., and Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350 (2004) 664-671
107. Bulduk E., Gönül B., and Ozer C. Effects of vitamin C on muscle glycogen and oxidative events in experimental diabetes. Mol. Cell. Biochem. 292 (2006) 131-137
108. Delaigle A.M., Senou M., Guiot Y., Many M.C., and Brichard S.M. Induction of adiponectin in skeletal muscle of type 2 diabetic mice: in vivo and in vitro studies. Diabetologia 49 (2006) 1311-1323
109. Muellenbach E.A., Diehl C.J., Teachey M.K., Lindborg K.A., Archuleta T.L., Harrell N.B., Andersen G., Somoza V., Hasselwander O., Matuschek M., and Henriksen E.J. Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant alpha-lipoic acid on insulin resistance in the obese Zucker rat. Metabolism 57 (2008) 1465-1472
110. Su H.C., Hung L.M., and Chen J.K. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E1339-E1346
111. Mastrocola R., Reffo P., Penna F., Tomasinelli C.E., Boccuzzi G., Baccino F.M., Aragno M., and Costelli P. Muscle wasting in diabetic and tumor-bearing rats: role of oxidative stress. Free Radic. Biol. Med. 44 (2008) 584-593
112. Jacob S., Ruus P., Hermann R., Tritschler H.J., Maerker E., Renn W., Augustin H.J., Dietze G.J., and Rett K. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic. Biol. Med. 27 (1999) 309-314
113. Prolisso G., D'Amore A., Galzerano D., Balbi V., Giugliano D., Varricchio M., and D'Onofrio F. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care 16 (1993) 1433-1437
114. Prolisso G., Di Maro G., Pizza G., D'Amore A., Sgambato S., Tesauro P., Varricchio M., and D'Onofrio F. Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics. Am. J. Physiol. 263 (1992) E435-440
115. Chen H., Karne R.J., Hall G., Campia U., Panza J.A., Cannon III R.O., Wang Y., Katz A., Levine M., and Quon M.J. High-dose oral vitamin C partially replenishes vitamin C levels in patients with type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H137-145
116. Wright D., and Sutherland L. Antioxidant supplementation in the treatment of skeletal muscle insulin resistance: potential mechanisms and clinical relevance. Appl. Physiol. Nutr. Metab. 33 (2008) 21-31
117. Lumini J.A., Magalhães J., Oliveira P.J., and Ascensão A. Beneficial effects of exercise on muscle mitochondrial function in diabetes mellitus. Sports Med. 38 (2008) 735-750
118. Brocca L., D'Antona G., Bachi A., and Pellegrino M.A. Amino acid supplements improve native antioxidant enzyme expression in the skeletal muscle of diabetic mice. Am. J. Cardiol. 101 (2008) 57E-62E
119. Laviano A., Meguid M.M., Preziosa I., and Rossi Fanelli F. Oxidative stress and wasting in cancer. Curr. Opin. Clin. Nutr. Metab. Care 10 (2007) 449-456
120. Barreiro E., De La Puente B., Busquets S., Lopez-Soriano F.J., Gea J., and Argiles J.M. Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats. FEBS Lett. 579 (2005) 1646-1652
121. Mantovani G., Macciò A., Madeddu C., Mura L., Massa E., Gramignano G., Lusso M.R., Murgia V., Camboni P., and Ferreli L. Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment. J. Cell. Mol. Med. 6 (2002) 570-582
122. Mantovani G., Maccio A., Madeddu C., Mura L., Gramignano G., Lusso M.R., Massa E., Mocci M., and Serpe R. Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress. J. Mol. Med. 81 (2003) 664-673
123. Mantovani G., Macciò A., Massa E., and Madeddu C. Managing cancer-related anorexia/cachexia. Drugs 61 (2001) 499-514
124. Mantovani G., Macciò A., Lai P., Massa E., Ghiani M., and Santona M.C. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Semin. Oncol. 25 (1998) 45-52
125. Weijl N.I., Cleton F.J., and Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat. Rev. 23 (1997) 209-240
126. Cha S.H., Rodgers J.T., Puigserver P., Chohnan S., and Lane M.D. Hypothalamic malonyl-CoA triggers mitochondrial biogenesis and oxidative gene expression in skeletal muscle: role of PGC-1alpha. Proc. Natl. Acad. Sci. USA 103 (2006) 15410-15415
127. Frascaria T., Laviano A., Bertini G., Citro G., Mantovani G., and Rossi Fanelli F. Antioxidant-enriched diet improves anorexia in tumor bearing rats. e-SPEN. Eur. e-J. Clin. Nutr. Metab. 1 (2006) 61 [Abstract]
128. Frascaria T., Laviano A., Bertini G., Ramaccini C., Citro G., Molfino A., Meguid M.M., and Rossi Fanelli F. Carnitine administration reduces cytokine levels, improves food intake and ameliorates body composition in tumor-bearing (TB) rats. e-SPEN. Eur. e-J. Clin. Nutr. Metab. 1 (2006) 31-32 [Abstract]
129. Ushmorov A., Hack V., and Dröge W. Differential reconstitution of mitochondrial respiratory chain activity and plasma redox state by cysteine and ornithine in a model of cancer cachexia. Cancer Res. 59 (1999) 3527-3534
130. Busquets S., Fuster G., Ametller E., Olivan M., Figueras M., Costelli P., Carbó N., Argilés J.M., and López-Soriano F.J. Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models. Clin. Nutr. 26 (2007) 239-244
131. Mantovani G., Macciò A., Madeddu C., Gramignano G., Serpe R., Massa E., Dessì M., Tanca F.M., Sanna E., Deiana L., Panzone F., Contu P., and Floris C. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results. Nutrition 24 (2008) 305-313
132. Gramignano G., Lusso M.R., Madeddu C., Massa E., Serpe R., Deiana L., Lamonica G., Dessì M., Spiga C., Astara G., Macciò A., and Mantovani G. Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy. Nutrition 22 (2006) 136-145
133. Distad B.J., Meekins G.D., Liou L.L., Weiss M.D., Carter G.T., and Miller R.G. Drug therapy in amyotrophic lateral sclerosis. Phys. Med. Rehabil. Clin. North Am. 19 (2008) 633-651
134. Muller F.L., Song W., Liu Y., Chaudhuri A., Pieke-Dahl S., Strong R., Huang T.T., Epstein C.J., Roberts II L.J., Csete M., Faulkner J.A., and Van Remmen H. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic. Biol. Med. 40 (2006) 1993-2004
135. Dineley K.E., Votyakova T.V., and Reynolds I.J. Zinc inhibition of cellular energy production: implications for mitochondria and neurodegeneration. J. Neurochem. 85 (2003) 563-570
136. Nishitoh H., Kadowaki H., Nagai A., Maruyama T., Yokota T., Fukutomi H., Noguchi T., Matsuzawa A., Takeda K., and Ichijo H. ALS-linked mutant SOD1 induces ER stress-and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 22 (2008) 1451-1464
137. Wiedau-Pazos M., Goto J.J., Rabizadeh S., Gralla E.B., Roe J.A., Lee M.K., Valentine J.S., and Bredesen D.E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271 (1996) 515-518
138. Estévez A.G., Crow J.P., Sampson J.B., Reiter C., Zhuang Y., Richardson G.J., Tarpey M.M., Barbeito L., and Beckman J.S. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286 (1999) 2498-2500
139. Smith A.P., and Lee N.M. Role of zinc in ALS. Amyotroph. Lateral Scler. 8 (2007) 131-143
140. Benatar M. Lost in translation: treatment trials in the SOD1 mice and in human ALS. Neurobiol. Dis. 26 (2007) 1-13
141. Weishaupt J.H., Bartels C., Pölking E., Dietrich J., Rohde G., Poeggeler B., Mertens N., Sperling S., Bohn M., Hüther G., Schneider A., Bach A., Sirén A.L., Hardeland R., Bähr M., Nave K.A., and Ehrenreich H. Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J. Pineal Res. 41 (2006) 313-323
142. Ito H., Wate R., Zhang J., Ohnishi S., Kaneko S., Ito H., Nakano S., and Kusaka H. Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice. Exp. Neurol. 213 (2008) 448-455
143. Orrell R.W., Lane R.J., and Ross M.A. systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Amyotroph. Lateral Scler. 9 (2008) 195-211
144. Grosso S., Perrone S., Longini M., Bruno C., Minetti C., Gazzolo D., Balestri P., and Buonocore G. Isoprostanes in dystrophinopathy: evidence of increased oxidative stress. Brain Dev. 30 (2008) 391-395
145. Tidball J.G., and Wehling-Henricks M. The role of free radicals in muscular dystrophy. J. Appl. Physiol. 102 (2007) 1677-1686
146. Brenman J.E., Chao D.S., Xia H., Aldape K., and Bredt D.S. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82 (1995) 743-752
147. Rando T.A. Role of nitric oxide in the pathogenesis of muscular dystrophies: a "two hit" hypothesis of the cause of muscle necrosis. Microsc. Res. Tech. 55 (2001) 223-235
148. Buetler T.M., Renard M., Offord E.A., Schneider H., and Ruegg U.T. Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species. Am. J. Clin. Nutr. 75 (2002) 749-753
149. Messina S., Altavilla D., Aguennouz M., Seminara P., Minutoli L., Monici M.C., Bitto A., Mazzeo A., Marini H., Squadrito F., and Vita G. Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Am. J. Pathol. 168 (2006) 918-926
150. Dorchies O.M., Wagner S., Vuadens O., Waldhauser K., Buetler T.M., Kucera P., and Ruegg U.T. Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. Am. J. Physiol. Cell. Physiol. 290 (2006) C616-C625
151. Call J.A., Voelker K.A., Wolff A.V., McMillan R.P., Evans N.P., Hulver M.W., Talmadge R.J., and Grange R.W. Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract. J. Appl. Physiol. 105 (2008) 923-932
152. Whitehead N.P., Pham C., Gervasio O.L., and Allen D.G. N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J. Physiol. 586 (2008) 2003-2014
153. Mok E., Eléouet-Da Violante C., Daubrosse C., Gottrand F., Rigal O., Fontan J.E., Cuisset J.M., Guilhot J., and Hankard R. Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy. Am. J. Clin. Nutr. 83 (2006) 823-828
154. Mok E., Constantin B., Favreau F., Neveux N., Magaud C., Delwail A., and Hankard R. l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice. Pediatr. Res. 63 (2008) 268-273
155. Boveris, Cadenas E., and Stoppani A.O. Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem. J. 156 (1976) 435-444